Context TherapeuticsCNTX
13F holders, Q2 2024 (June 30)34holders +9
19new positions
9sold out
1famous investor
$2.00avg. 13F price*
At the end of Q2 2024, 34 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, up 9 from Q1 2024. 19 opened new positions and 9 sold out. The largest holders were Great Point Partners LLC ($14.9M), Nextech Invest Ltd. ($14.9M) and Avidity Partners Management LP ($14.9M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 19 | $93.9M |
| Exits | 9 | $1.6M |
All 13F filers, Q1 2024 → Q2 2024: 54,361,873 shares bought and 1,262,264 shares sold, net +53,099,609 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Great Point Partners LLC | 2.85% | New | 7,419,355 | $14.9M |
| Nextech Invest Ltd. | 2.50% | New | 7,419,355 | $14.9M |
| Avidity Partners Management LP | 0.63% | New | 7,419,355 | $14.9M |
| Deep Track Capital, LP | 0.44% | New | 7,419,355 | $14.9M |
| Blue Owl Capital Holdings LP | 2.88% | New | 5,161,290 | $10.3M |
| Vanguard Group Inc. | 0.00% | Add +652.5% | 4,502,198 | $9.0M |
| Driehaus Capital Management LLC | 0.04% | New | 2,258,065 | $4.5M |
| Nantahala Capital Management, LLC | 0.39% | New | 1,935,484 | $3.9M |
| Alyeska Investment Group, L.P. | 0.02% | New | 1,935,484 | $3.9M |
| Ally Bridge Group (NY) LLC | 2.25% | Add +159.8% | 1,886,232 | $3.8M |
| Blackstone Inc. | 0.02% | New | 1,838,709 | $3.7M |
| Affinity Asset Advisors, LLC | 0.56% | Add +392.4% | 1,619,140 | $3.2M |
| Sio Capital Management, LLC | 1.00% | New | 1,328,352 | $2.7M |
| Velan Capital Investment Management LP | 1.48% | New | 1,290,323 | $2.6M |
| BlackRock Inc. | 0.00% | New | 851,696 | $1.7M |
| ADAR1 Capital Management, LLC | 0.26% | Add +213.3% | 645,161 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +511.6% | 618,174 | $1.2M |
| Altium Capital Management LLC | 0.30% | New | 360,001 | $722K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Reduce -1.0% | 293,758 | $589K |
| Northern Trust Corp. | 0.00% | Add +368.8% | 174,497 | $350K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $252K |
| Walleye Capital LLC | 0.00% | New | 108,376 | $217K |
| Mill Creek Capital Advisors, LLC | 0.01% | No change | 104,631 | $210K |
| State Street Corp. | 0.00% | Add +179.9% | 92,107 | $185K |
| Renaissance Technologies | 0.00% | Add +63.4% | 65,200 | $131K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -60.8% | 41,469 | $83K |
| Clear Harbor Asset Management, LLC | 0.01% | No change | 36,000 | $72K |
| ExodusPoint Capital Management, LP | 0.00% | New | 24,750 | $50K |
| Caxton Corp. | 0.19% | New | 18,403 | $37K |
| Verition Fund Management LLC | 0.00% | New | 16,294 | $33K |
| Two Sigma Investments, LP | 0.00% | New | 13,844 | $28K |
| Bank of America Corp. | 0.00% | New | 10,776 | $22K |
| Osaic Holdings, Inc. | 0.00% | Reduce -66.7% | 500 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $802 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.